NRC Health NRC
$21.12
-$0.14-0.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.98% | 3.73% | -4.64% | -3.38% | -2.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.98% | 3.73% | -4.64% | -3.38% | -2.81% |
| Cost of Revenue | 4.55% | 4.51% | -2.89% | -18.95% | -3.34% |
| Gross Profit | 3.63% | 3.24% | -5.75% | 8.24% | -2.48% |
| SG&A Expenses | 78.34% | 29.58% | -30.63% | 11.68% | -1.13% |
| Depreciation & Amortization | 21.76% | 40.66% | 41.49% | 41.98% | 15.14% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.43% | 17.15% | -11.91% | -3.48% | -1.32% |
| Operating Income | -100.95% | -35.21% | 15.43% | -3.03% | -7.19% |
| Income Before Tax | -880.90% | -43.30% | -63.17% | -14.02% | -93.02% |
| Income Tax Expenses | -282.53% | -40.24% | -36.46% | 33.77% | -68.03% |
| Earnings from Continuing Operations | -2,997.17% | -44.32% | -72.59% | -27.53% | -101.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2,997.17% | -44.32% | -72.59% | -27.53% | -101.72% |
| EBIT | -100.95% | -35.21% | 15.43% | -3.03% | -7.19% |
| EBITDA | -79.51% | -23.67% | 18.92% | 4.27% | -3.93% |
| EPS Basic | -1,686.90% | -43.75% | -72.52% | -24.73% | -103.25% |
| Normalized Basic EPS | -119.63% | -40.22% | 16.92% | -7.80% | -8.58% |
| EPS Diluted | -1,401.00% | -44.00% | -74.40% | -24.94% | -103.87% |
| Normalized Diluted EPS | -119.63% | -40.55% | 16.89% | -7.71% | -8.41% |
| Average Basic Shares Outstanding | -2.86% | -5.11% | -6.71% | -6.71% | -5.08% |
| Average Diluted Shares Outstanding | -2.86% | -4.63% | -6.67% | -6.80% | -5.26% |
| Dividend Per Share | 33.33% | 33.33% | 33.33% | 0.00% | 0.00% |
| Payout Ratio | 0.96% | 1.35% | 2.49% | 0.34% | -56.57% |